Search hospitals > Ontario > TORONTO
Sunnybrook Health Sciences Centre
Claim this profileTORONTO, Ontario M4N 3M5
Global Leader in Prostate Cancer
Global Leader in Breast Cancer
Conducts research for Alzheimer's Disease
Conducts research for Depression
Conducts research for Cancer
803 reported clinical trials
107 medical researchers
Summary
Sunnybrook Health Sciences Centre is a medical facility located in TORONTO, Ontario. This center is recognized for care of Prostate Cancer, Breast Cancer, Alzheimer's Disease, Depression, Cancer and other specialties. Sunnybrook Health Sciences Centre is involved with conducting 803 clinical trials across 751 conditions. There are 107 research doctors associated with this hospital, such as Paul Karanicolas, MD, PhD, Sandra Black, MD, Laurence Klotz, MD, and Gregory J Czarnota, PhD, MD.Area of expertise
1Prostate Cancer
Global LeaderStage IV
PSA positive
ALT positive
2Breast Cancer
Global LeaderStage IV
HER2 negative
Stage III
Top PIs
Paul Karanicolas, MD, PhDSunnybrook Health Sciences Centre6 years of reported clinical research
Studies Tumors
Studies Surgery
9 reported clinical trials
21 drugs studied
Sandra Black, MDSunnybrook Health Sciences Centre5 years of reported clinical research
Studies Alzheimer's Disease
Studies Mild Cognitive Impairment
10 reported clinical trials
21 drugs studied
Laurence Klotz, MDSunnybrook Health Sciences Centre5 years of reported clinical research
Studies Prostate Cancer
Studies Recurrence
8 reported clinical trials
17 drugs studied
Gregory J Czarnota, PhD, MDSunnybrook Health Sciences Centre9 years of reported clinical research
Studies Breast Cancer
Studies Head and Neck Cancers
8 reported clinical trials
13 drugs studied
Clinical Trials running at Sunnybrook Health Sciences Centre
Prostate Cancer
Depression
Coronavirus
Bleeding
Non-Small Cell Lung Cancer
Stroke
Atrial Fibrillation
Pneumonia
Traumatic Brain Injury
Syndrome
ADT + Apalutamide
for Prostate Cancer
The purpose of the study is to determine if the intermittent use of androgen-deprivation therapy (ADT) in participants with metastatic castrate-sensitive prostate cancer (mCSPC) who reached a prostate-specific antigen (PSA) level \< 0.2 nanograms/millilitres (ng/mL) after 6 months of treatment with apalutamide and ADT combination therapy provides non-inferior radiographic progression-free survival (rPFS) and a reduced burden of hot flashes measured as 18-month percent change in severity adjusted hot flash score.
Recruiting2 awards Phase 37 criteria
SABR Treatments
for Prostate Cancer
Prostate Stereotactic ablative body radiotherapy (SABR) is an established technique that delivers radiation in a non-invasive approach for men with prostate cancer. The treatment regimen is given in total of 5 fractions with one treatment per day at every other day or weekly sessions. Ultra-hypofractionated radiotherapy (UHRT) is an emerging monotherapy for localized prostate cancer however, several trials have observed demonstrating superior biochemical control of a two-fraction (HDR) over single-fraction approach. The study aims to compare an experimental shorter course of prostate ultra-hypofractionated radiotherapy (UHRT) that will deliver what is expected to be an equivalent amount of radiation as given in the standard 5 treatment regimen. UHRT is given in 2 treatments with one treatment a week for 2 consecutive weeks.
Recruiting1 award N/A2 criteria
ctDNA-Guided Therapy
for Prostate Cancer
This trial tests if using a blood marker to choose between two treatments is better than doctors choosing the treatment for advanced prostate cancer patients who did not respond to previous therapy.
Recruiting1 award Phase 220 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Sunnybrook Health Sciences Centre?
Sunnybrook Health Sciences Centre is a medical facility located in TORONTO, Ontario. This center is recognized for care of Prostate Cancer, Breast Cancer, Alzheimer's Disease, Depression, Cancer and other specialties. Sunnybrook Health Sciences Centre is involved with conducting 803 clinical trials across 751 conditions. There are 107 research doctors associated with this hospital, such as Paul Karanicolas, MD, PhD, Sandra Black, MD, Laurence Klotz, MD, and Gregory J Czarnota, PhD, MD.
Where is Sunnybrook Health Sciences Centre located?
Sunnybrook Health Sciences Centre is situated at 2075 Bayview Ave, Toronto, ON M4N 3M5, close to the Bayview Ave and Eglinton Ave E intersection. It also offers an underground parking garage accessible on Church Street, north of Maitland Street.
Who should I call to ask about financial aid or insurance network?
For general inquiries, email Sunnybrook Health Sciences Centre at questions@sunnybrook.ca. For patient care concerns or comments, contact the patient experience office at 416-480-4940. Financial assistance and community support inquiries can be directed to 2-1-1. For drug reimbursement, visit TG-230 in the Odette Cancer Centre or call 416-480-4623. The Sunnybrook Foundation can be reached at 416-480-4483 or visit www.sunnybrook.ca/foundation.
What insurance does Sunnybrook Health Sciences Centre accept?
Sunnybrook Health Sciences Centre accepts the Ontario Health Insurance Plan (OHIP) for eligible patients. Non-OHIP patients can access billing information and payment details for medical services. Patients should bring their health card, extended health insurance policy information, and motor vehicle insurance provider details to their first appointment.
What awards or recognition has Sunnybrook Health Sciences Centre received?
Sunnybrook Health Sciences Centre, located in Toronto, Ontario, is a world-leading healthcare institution and a fully affiliated teaching hospital of the University of Toronto. It is renowned for its groundbreaking healthcare research, significantly impacting global patient treatment. The Sunnybrook Research Institute boasts over 360 scientists, 11 Canada Research Chairs, involvement in 500+ active clinical trials, 1700 annual publications, and the establishment of 20 start-up companies.